Company intelligence / Profile preview

GA Investors

New York, New York, United States

Ownership: Private
Employees: ~500
Development stage: Other

Overview

General Atlantic is a leading global growth equity firm that provides capital and strategic support for growth-stage companies across several sectors, including Life Sciences and Healthcare. The firm's healthcare portfolio focuses on innovative companies in biotechnology, digital health, and healthcare services that aim to improve patient outcomes and system efficiencies. General Atlantic typically employs a long-term investment horizon, partnering with management teams to scale operations globally. Notable investments in the life sciences space include companies like Ginkgo Bioworks, Immunocore, and Royuant Sciences.

Industry: Investors

Beyond the preview

Go deeper on GA Investors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GA Investors.

Explore the full profile